These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11272201)

  • 1. Roles of ATP-sensitive K+ channels in cell survival and differentiation in the endocrine pancreas.
    Miki T; Iwanaga T; Nagashima K; Ihara Y; Seino S
    Diabetes; 2001 Feb; 50 Suppl 1():S48-51. PubMed ID: 11272201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse roles of K(ATP) channels learned from Kir6.2 genetically engineered mice.
    Seino S; Iwanaga T; Nagashima K; Miki T
    Diabetes; 2000 Mar; 49(3):311-8. PubMed ID: 10868950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulated expression of adenosine triphosphate-sensitive potassium channel subunits in pancreatic beta-cells.
    Moritz W; Leech CA; Ferrer J; Habener JF
    Endocrinology; 2001 Jan; 142(1):129-38. PubMed ID: 11145575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological changes in pancreatic islets of KATP channel-deficient mice: the involvement of KATP channels in the survival of insulin cells and the maintenance of islet architecture.
    Winarto A; Miki T; Seino S; Iwanaga T
    Arch Histol Cytol; 2001 Feb; 64(1):59-67. PubMed ID: 11310506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous recovery from hyperglycemia by regeneration of pancreatic beta-cells in Kir6.2G132S transgenic mice.
    Oyama K; Minami K; Ishizaki K; Fuse M; Miki T; Seino S
    Diabetes; 2006 Jul; 55(7):1930-8. PubMed ID: 16804060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of pancreatic islets by targeted expression of a dominant-negative KATP channel.
    Miki T; Tashiro F; Iwanaga T; Nagashima K; Yoshitomi H; Aihara H; Nitta Y; Gonoi T; Inagaki N; Miyazaki Ji; Seino S
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11969-73. PubMed ID: 9342346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of the ATP-sensitive K+ channel subunit Kir6.2 in mouse pancreas.
    Suzuki M; Fujikura K; Inagaki N; Seino S; Takata K
    Diabetes; 1997 Sep; 46(9):1440-4. PubMed ID: 9287044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
    Cui Y; Tinker A; Clapp LH
    Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose controls cytosolic Ca2+ and insulin secretion in mouse islets lacking adenosine triphosphate-sensitive K+ channels owing to a knockout of the pore-forming subunit Kir6.2.
    Ravier MA; Nenquin M; Miki T; Seino S; Henquin JC
    Endocrinology; 2009 Jan; 150(1):33-45. PubMed ID: 18787024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biology of adenosine triphosphate-sensitive potassium channels.
    Aguilar-Bryan L; Bryan J
    Endocr Rev; 1999 Apr; 20(2):101-35. PubMed ID: 10204114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of Kir6.2-SUR1 currents, in the absence and presence of sodium azide, to the K(ATP) channel inhibitors, ciclazindol and englitazone.
    McKay NG; Kinsella JM; Campbell CM; Ashford ML
    Br J Pharmacol; 2000 Jun; 130(4):857-66. PubMed ID: 10864893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells.
    Yokoshiki H; Sunagawa M; Seki T; Sperelakis N
    Am J Physiol; 1998 Jan; 274(1):C25-37. PubMed ID: 9458709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.
    Chachin M; Yamada M; Fujita A; Matsuoka T; Matsushita K; Kurachi Y
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1025-32. PubMed ID: 12604678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fluoroquinolones on insulin secretion and beta-cell ATP-sensitive K+ channels.
    Saraya A; Yokokura M; Gonoi T; Seino S
    Eur J Pharmacol; 2004 Aug; 497(1):111-7. PubMed ID: 15321742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
    Gribble FM; Tucker SJ; Seino S; Ashcroft FM
    Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant.
    Yamada S; Kane GC; Behfar A; Liu XK; Dyer RB; Faustino RS; Miki T; Seino S; Terzic A
    J Physiol; 2006 Dec; 577(Pt 3):1053-65. PubMed ID: 17038430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCC-134, a novel vascular relaxing agent, is an inverse agonist for the pancreatic-type ATP-sensitive K(+) channel.
    Shindo T; Katayama Y; Horio Y; Kurachi Y
    J Pharmacol Exp Ther; 2000 Jan; 292(1):131-5. PubMed ID: 10604939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP4- mediates closure of pancreatic beta-cell ATP-sensitive potassium channels by interaction with 1 of 4 identical sites.
    Markworth E; Schwanstecher C; Schwanstecher M
    Diabetes; 2000 Sep; 49(9):1413-8. PubMed ID: 10969823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mitiglinide (S 21403) on Kir6.2/SUR1, Kir6.2/SUR2A and Kir6.2/SUR2B types of ATP-sensitive potassium channel.
    Reimann F; Proks P; Ashcroft FM
    Br J Pharmacol; 2001 Apr; 132(7):1542-8. PubMed ID: 11264248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKA-mediated phosphorylation of the human K(ATP) channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation.
    Béguin P; Nagashima K; Nishimura M; Gonoi T; Seino S
    EMBO J; 1999 Sep; 18(17):4722-32. PubMed ID: 10469651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.